DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

André F, OʼRegan R, Ozguroglu M et al.
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.

Lancet Oncol 2014;
15: 580-591

Download Bibliographical Data

Search in:
Access: